Carina Schey
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Impact of restricted access to, and low awareness of, mexiletine on people with myotonia: a real-world European survey.
Journal: Neuromuscular disorders : NMD
Published: April 28, 2022
Assessing the Preferences for Criteria in Multi-Criteria Decision Analysis in Treatments for Rare Diseases.
Journal: Frontiers in public health
Published: August 08, 2019
Metastatic Renal Cell Cancer: An Analysis of Reimbursement Decisions.
Journal: Advances in therapy
Published: November 26, 2018
Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis.
Journal: Pathogens and global health
Published: January 17, 2017
Multi-criteria decision analysis (MCDA): testing a proposed MCDA framework for orphan drugs.
Journal: Orphanet journal of rare diseases
Published: September 24, 2016
Assessing The Relationship Between Individual Attributes Identified In Review Of Multi-Criteria Decision Analysis (MCDA) Of Rare Diseases And Annual Treatment Costs In Rare Endocrine Disorders.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Multi-Criteria Decision Analysis (MCDA): Testing a Proposed Mcda Model for Orphan Drugs.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Are antibiotic Policies and Reimbursement Decisions Aligned?
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Estimating the budget impact of orphan drugs in Sweden and France 2013-2020.
Journal: Orphanet journal of rare diseases
Published: October 25, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026